Eva Tomiak

Adjuvant Docetaxel for Node-Positive Breast Cancer

Miguel Martín, Tadeusz Pieńkowski, John R. Mackey et al. · New England Journal of Medicine · 2005 · 952 citations · Full text

Medicine, Oncology, Pharmacology +13

Prospective Randomized Trial of Docetaxel Versus Mitomycin Plus Vinblastine in Patients With Metastatic Breast Cancer Progressing Despite Previous Anthracycline-Containing Chemotherapy

Jean‐Marc Nabholtz, H.-J. Senn, W.R. Bezwoda et al. · Journal of Clinical Oncology · 1999 · 506 citations

Medicine, Oncology, Pharmacology +12

Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type

Leora Witkowski, Jian Carrot‐Zhang, Steffen Albrecht et al. · Nature Genetics · 2014 · 500 citations

Medicine, Genetics, Oncology +14

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes

A. C. Lionel, Kristiina Tammimies, Andrea K. Vaags et al. · Human Molecular Genetics · 2013 · 175 citations · Full text

Life Sciences, Genetics, Neuroscience +17

The cognitive effects of adjuvant chemotherapy in early stage breast cancer: a prospective study

Angela Stewart, Barbara Collins, Joyce MacKenzie et al. · Psycho-Oncology · 2007 · 156 citations

Medicine, Oncology, Psychology +16